Pascale Boissel
Director/Board Member bei POXEL
Vermögen: 2 360 $ am 31.03.2024
Profil
Ms. Pascale Boissel is an Independent Member-Supervisory Board at Innate Pharma SA, an Independent Non-Executive Director at Sartorius Stedim Biotech SA and an Independent Director at Poxel SA. She is on the Board of Directors at Innate Pharma SA, Sartorius Stedim Biotech SA and Poxel SA. Ms. Boissel was previously employed as a CFO, Director-Finance & Administration by ENYO Pharma SA, a Chief Financial Officer by Novadiscovery SAS, a Director-Finance & Administration & Deputy CEO by BioAster, and a Chief Financial Officer & Head-Media Relations by Ipsogen SA. She received her undergraduate degree from École des Hautes Études Commerciales de Paris and an MBA from École des Hautes Études Commerciales de Paris.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INNATE PHARMA SA CLASS A
0,00% | 31.12.2022 | 1 000 ( 0,00% ) | 2 360 $ | 31.03.2024 |
Aktive Positionen von Pascale Boissel
| Unternehmen | Position | Beginn |
|---|---|---|
| POXEL | Director/Board Member | 05.03.2015 |
| SARTORIUS STEDIM BIOTECH | Director/Board Member | 26.03.2019 |
| INNATE PHARMA | Director/Board Member | 19.05.2020 |
Ehemalige bekannte Positionen von Pascale Boissel
| Unternehmen | Position | Ende |
|---|---|---|
Novadiscovery SAS
 Novadiscovery SAS Information Technology ServicesTechnology Services Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France. | Director of Finance/CFO | 01.01.2021 |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Director of Finance/CFO | 01.05.2018 |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Director of Finance/CFO | 01.12.2016 |
| QIAGEN MARSEILLE | Director of Finance/CFO | 01.01.2012 |
Ausbildung von Pascale Boissel
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| POXEL | Health Technology |
| INNATE PHARMA | Health Technology |
| SARTORIUS STEDIM BIOTECH | Health Technology |
| Private Unternehmen | 4 |
|---|---|
QIAGEN Marseille SA
 QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services QIAGEN Marseille SA is a molecular diagnosis company, which focuses on the development and marketing of diagnostic tests in the field of oncology. Its products are used for diagnosis, prognosis and monitoring of patients with leukemia. The company was founded by Vincent Fert, Stéphane Debono, and Fabienne Hermitte on September 23, 1999 and is headquartered in Marseille, France. | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France. | Technology Services |
